Net profit of Medicamen Biotech rose 13.62% to Rs 2.42 crore in the quarter ended March 2025 as against Rs 2.13 crore during the previous quarter ended March 2024. Sales declined 37.43% to Rs 29.61 crore in the quarter ended March 2025 as against Rs 47.32 crore during the previous quarter ended March 2024.
For the full year,net profit declined 34.95% to Rs 7.11 crore in the year ended March 2025 as against Rs 10.93 crore during the previous year ended March 2024. Sales declined 9.35% to Rs 162.55 crore in the year ended March 2025 as against Rs 179.31 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 29.61 | 47.32 | -37 | 162.55 | 179.31 | -9 |
| OPM % | -5.44 | 12.15 | - | 8.53 | 12.40 | - |
| PBDT | 2.97 | 4.43 | -33 | 16.95 | 20.17 | -16 |
| PBT | 2.49 | 2.66 | -6 | 9.88 | 13.08 | -24 |
| NP | 2.42 | 2.13 | 14 | 7.11 | 10.93 | -35 |